Scintomics Molecular, Applied Theranostics Technologies (SCI-att) is a growing player in the radiopharmaceutical business with a particular strategic emphasis on providing unrestricted supply and support of proprietary and innovative tracer technology and non-IP protected precursors, such as PSMA I&T and next generation PSMA inhibitors for radioligand therapy such as siPSMA-14.

The well-known GRP Module Series became part of SCI-att in 2020 when SCI-att took over the Module business from its parent company Scintomics, which has been selling and installing fully automated production systems for established radio-pharmaceuticals in clinical facilities around the world since 2006.

Scintomics Molecular ATT

Org chart

Teams

Offices

Scintomics Molecular ATT

Org chart

Teams

Offices

Related companies